论文信息 - A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19 - 字舞流文

A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19

M. Sadelain | M. Heaney | R. Brentjens | I. Rivière | D. Hollyman | J. Stefanski | Clare Taylor | M. Weiss | S. Bartido | M. Przybylowski | Oriana Bórquez-Ojeda